Agarose Bead Technologies emphasizes purification importance for mRNA vaccines
The post notes a 49% reduction in melanoma recurrence risk with personalized mRNA vaccine and Keytruda, citing purification advances.
See the latest news and media coverage for Agarose Bead Technologies. We track all announcements, press releases, and industry mentions in real time, all in one place.
High-performance agarose resins for bioprocessing
abtbeads.comLast updated
In short: Agarose Bead Technologies expanded its Spanish facilities, grew its leadership team, and celebrated 25 years of bioprocessing innovation.
The post notes a 49% reduction in melanoma recurrence risk with personalized mRNA vaccine and Keytruda, citing purification advances.
She brings over 15 years of experience from a multinational food company.
The company highlights its journey from scientific foundation to trusted global bioprocessing partner, built on innovation and partnerships. It anticipates future growth.
The Spanish Ministry of Science, Innovation and Universities awards it for R&D investments. This confirms ABT's commitment to bioprocessing innovation.
A practical guide to making agarose gels for electrophoresis, from choosing the right percentage to avoiding common mistakes.
Liquid Biopsy: Understand the significance of liquid biopsy in cancer research and the role of magnetic beads in sample preparation: After listening to the podcast...
Agarose Bead Technologies (ABT), a manufacturer of high-quality agarose resins has today announced plans for further expansion, reinforcing its position as a strategic partner for...
Agarose Bead Technologies (ABT), a key player in the life science industry, plans a major expansion of its manufacturing capabilities, tripling its production capacity to...
Track Agarose Bead Technologies and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.